Local view for "http://purl.org/linkedpolitics/eu/plenary/2013-02-06-Speech-3-208-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2013-02-06"^^xsd:date2
dcterms:Is Part Of	lp_eu:Transparency of measures regulating the prices of medicinal products for human use (A7-0015/2013 - Antonyia Parvanova)2
dcterms:Language	"en"^^xsd:language2
lpv:document identification number	"en.20130206.25.3-208-000"2
lpv:hasSubsequent	lp_eu:2013-02-06-Speech-3-209-0002
lpv:speaker	lp:David Martin2
lpv:spoken text	"I welcome this report and the proposed 60-day time limit to decide on the pricing and reimbursement of generic medicines, in order to speed up their availability and save money for patients and social security systems. Decisions concerning new medicines will have to respect the current deadline of 180 days. According to the European Commission, generic products are on average 40% cheaper than the original branded medicines, once they have been available for two years. An enquiry showed that companies use various means to extend the period when they can market their medicines exclusively, without competition from generics."@en1
lpv:spokenAs	member; Delegation for relations with the Korean Peninsula (2009-09-17--2014-06-30)3 member; INTA (2012-01-19--2014-06-30)3 member; AFCO (2012-01-19--2014-06-30)3 member; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-16--2014-06-30)3 chair; Delegation to the Cariforum — EU Parliamentary Committee (2010-09-08--2014-06-30)3 unknown; Labour Party (2009-07-14--2014-06-30)3 member; S&D (2009-07-14--2014-06-30)3 member; DROI (2012-01-19--2014-06-30)3 member; Conference of Delegation Chairs (2010-09-08--2014-06-30)3 substitute; Delegation for relations with Australia and New Zealand (2013-01-11--2014-06-30)3
lpv:unclassifiedMetadata	"David Martin (S&D ),"1 "in writing"1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph